AYTU BIOPHARMA, INC Increase (Decrease) in Security Deposits
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Security Deposits of -$193 for the 6-month period ending 2015-02-28, per its 10-Q filed 2015-04-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2015-04-15
- AYTU BIOPHARMA, INC increase (decrease) in security deposits for the quarter ending 2014-02-28 was $0.00.
- AYTU BIOPHARMA, INC increase (decrease) in security deposits for the quarter ending 2013-11-30 was $0.00.
- AYTU BIOPHARMA, INC increase (decrease) in security deposits for fiscal 2013 was -$288.00.
| Period end | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 12 month | Increase (Decrease) in Security Deposits 102 month | Increase (Decrease) in Security Deposits 105 month | Increase (Decrease) in Security Deposits 108 month |
|---|---|---|---|---|---|---|
| 2015-02-28 | -$193.00 10-Q · filed 2015-04-15 | |||||
| 2014-02-28 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2014-04-11 | $0.00 derived: sum of 2 quarters · filed 2014-04-11 | -$288.00 10-Q · filed 2014-04-11 | |||
| 2013-11-30 | $0.00 derived: 10-Q 105 month − 10-K 102 month · filed 2014-01-10 | -$288.00 10-Q · filed 2014-01-10 | ||||
| 2013-08-31 | -$288.00 10-K · filed 2014-11-26 | -$288.00 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |